Watch the interview with Saniona
Saniona’s CEO Thomas Feldthus and incoming Chairman of the Board John Haurum participated in a live interview at BioStock’s studio, where they answered investors’ questions. The discussion covered topics such as the prospects for a potential approval of tesofensine in Mexico, the company’s view on expansion in Brazil and South Korea, and the strategically important deal with Acadia. Additionally, they provided insights into upcoming milestones in Saniona’s broader pipeline.
Watch Thomas Feldthus and John Haurum respond to viewers’ questions below.
Note: Questions that there wasn’t time to answer will be addressed shortly in an upcoming written interview.
The content of BioStock’s news and analyses is independent but the work of BioStock is to a certain degree financed by life science companies. The above article concerns a company from which BioStock has received financing.
